glp-1 aesthetics news Big news, we've lowered our weight loss program pricing! Same medically supervised care. Same personalized support. Same life-changing results. Now at a price that makes your wellness goals more accessible than GLP-1 – Allure Aesthetics Med

FOXO4-DRI Human Trials: Status, Evidence Gaps, and What to Watch (2026) As of July 2026, no human trial of FOXO4-DRI has ever been registered or published

392:2089-2099 [PubMed: 40305708] 339

With NNMT blocked, nicotinamide stays in the cell, NAD+ levels climb, and fat cells start burning more fuel instead of storing it

Regulation of energy metabolism and mitochondrial function in skeletal muscle during lipid overfeeding in healthy men

Notable findings include: In the SURMOUNT-1 trial of tirzepatide for the treatment of obesity, secondary findings showed improvements in the GLP-1 treatment group in systolic blood pressure (-7.2mm Hg), diastolic blood pressure (-4.8mm Hg), triglycerides (-24.8mg/dl), fasting insulin (-42.9mIU liter), and total cholesterol (-4.8mg/dl)

Whether youre preparing for a big event or simply striving to fill your best every day, were here to help you look and feel amazing